Literature DB >> 20513115

Hydroxyurea in sickle cell disease: What will it take to change practice?

George F Atweh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20513115     DOI： 10.1002/ajh.21733

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

Review 1.  Replication stress and mechanisms of CNV formation.

Authors:  Martin F Arlt; Thomas E Wilson; Thomas W Glover
Journal:  Curr Opin Genet Dev       Date:  2012-02-23       Impact factor: 5.578

2.  Hydroxyurea induces de novo copy number variants in human cells.

Authors:  Martin F Arlt; Alev Cagla Ozdemir; Shanda R Birkeland; Thomas E Wilson; Thomas W Glover
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

3.  α:Non-α and Gγ:Aγ globin chain ratios in thalassemia intermedia patients treated with hydroxyurea.

Authors:  Abbas Najjari; Mohsen Asouri; Ladan Hosseini Gouhari; Haleh Akhavan Niaki; Amir Sasan Mozaffari Nejad; Seyyedeh Masoumeh Eslami; Hassan Abolghasemi; Ramin Ataee; Abdol Ali Ebrahimi; Masoumeh Rezaei Moshaei; Ali Asghar Ahmadi
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

4.  Hydroxyurea: A useful adjunct to the standard antiviral therapy in chronic hepatitis B.

Authors:  Mostafa Alavi-Moghaddam
Journal:  Hepat Mon       Date:  2011-03       Impact factor: 0.660

Review 5.  Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias.

Authors:  Wai Cheng Foong; Jacqueline J Ho; C Khai Loh; Vip Viprakasit
Journal:  Cochrane Database Syst Rev       Date:  2016-10-18

6.  Hydroxyurea treatment is associated with reduced degree of oxidative perturbation in children and adolescents with sickle cell anemia.

Authors:  Caian L Vinhaes; Rozana S Teixeira; Jay A S Monteiro-Júnior; Rafael Tibúrcio; Juan M Cubillos-Angulo; María B Arriaga; Adrielle G Sabarin; Amâncio J de Souza; Jacqueline J Silva; Isa M Lyra; Ana Marice Ladeia; Bruno B Andrade
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.